A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial.
Saved in:
| Title: | A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial. |
|---|---|
| Authors: | Wong KH; Department of Neurology, University of Utah, Salt Lake City, UT.; Salt Lake City Veterans Affairs Health System Medical Center, Salt Lake City, UT., Day GS; Department of Neurology, Mayo Clinic in Florida, Jacksonville, FL., Torner JC; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Cudkowicz M; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Coffey CS; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Cho HJS; The National Institute of Neurological Disorders and Stroke (NINDS), of the National Institutes of Health, Bethesda, MD., Utz U; The National Institute of Neurological Disorders and Stroke (NINDS), of the National Institutes of Health, Bethesda, MD., Clifford DB; Department of Neurology, Washington University, St. Louis, MO., Katz E; Formerly with Viela Bio at Time of Contributions; Viela Bio Was Subsequently Acquired By Horizon and Later Amgen, Thousand Oaks, CA., Ratchford J; Formerly with Viela Bio at Time of Contributions; Viela Bio Was Subsequently Acquired By Horizon and Later Amgen, Thousand Oaks, CA., Flavin S; Amgen, Thousand Oaks, CA., Dialino-Felix A; Amgen, Thousand Oaks, CA., Dill LM; Amgen, Thousand Oaks, CA., Kamp C; Clinical Materials Services Unit (CMSU) in the Center for Human Experimental Therapeutics (CHET), University of Rochester, Rochester, NY., Klawiter EC; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Singleton JR; Department of Neurology, University of Utah, Salt Lake City, UT.; Salt Lake City Veterans Affairs Health System Medical Center, Salt Lake City, UT., Fedler J; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Klingner EA; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Ecklund D; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Klements D; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Costigan M; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Steinhart E; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Pearson B; NeuroNEXT Data Coordinating Center, Clinical Trials Statistical Data Management Center, Department of Biostatistics, University of Iowa, IA., Desir C; Department of Neurology, NeuroNEXT Clinical Coordinating Center, Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, Harvard Medical School, Boston, MA., Dalmau JO; IDIBAPS-Hospital Clinic, University of Barcelona, Barcelona, Spain., Titulaer MJ; Department of Neurology, University Erasmus Medical Center, Rotterdam, the Netherlands., Clardy SL; Department of Neurology, University of Utah, Salt Lake City, UT.; Salt Lake City Veterans Affairs Health System Medical Center, Salt Lake City, UT. |
| Source: | Neurology open access [Neurol Open Access] 2025 Jun; Vol. 1 (2). Date of Electronic Publication: 2025 Apr 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health Inc. on behalf of the American Academy of Neurology Country of Publication: United States NLM ID: 9919033199906676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2998-7601 (Electronic) Linking ISSN: 29987601 NLM ISO Abbreviation: Neurol Open Access Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
